Pharmacological rationale for the clinical use of caffeine.
about
Seizure activity and unresponsiveness after hydroxycut ingestionOstracising caffeine from the pharmacological arsenal for attention-deficit hyperactivity disorder--was this a correct decision? A literature reviewWinning a Won Game: Caffeine Panacea for Obesity SyndemicThe Safety of Ingested Caffeine: A Comprehensive Review.Presence of caffeine reversibly interferes with efficacy of acupuncture-induced analgesiaImproved time to exhaustion following ingestion of the energy drink Amino Impact.Medication overuse headaches -- what is new?Arylamine N-acetyltransferases and drug response.Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans.A safety assessment of fixed combinations of acetaminophen and acetylsalicylic acid, coformulated with caffeine.Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.Xanthines down-regulate the drug transporter ABCG2 and reverse multidrug resistanceDevelopment of taste masked caffeine citrate formulations utilizing hot melt extrusion technology and in vitro-in vivo evaluationsCaffeine Mitigates Lung Inflammation Induced by Ischemia-Reperfusion of Lower Limbs in Rats.Examination of a pre-exercise, high energy supplement on exercise performanceComplexation of biologically active aromatic compounds with DNA in the presence of theophyllineImpact of caffeine on weight changes due to ketotifen administration.Efficacy of fixed combinations of acetylsalicyclic acid, acetaminophen and caffeine in the treatment of idiopathic headache: a review.Pharmacological treatment of postprandial reductions in blood pressure: a systematic review.Caffeine as an opioid analgesic adjuvant in fibromyalgiaOolong tea: A critical review of processing methods, chemical composition, health effects, and risk.Chemical Composition and Hypotensive Effect of Campomanesia xanthocarpa.The effect of acute pre-workout supplementation on power and strength performance.Potential activity of the purine compounds caffeine and aminophylline on bacteria.Chiropractic management of a patient with migraine headache.Caffeine augments proteinuria in puromycin-aminonucleoside nephrotic rats.Individual and mixture effects of caffeine and sulfamethoxazole on the daggerblade grass shrimp Palaemonetes pugio following maternal exposure.Theobromine as undesirable substances in animal feed - Scientific opinion of the Panel on Contaminants in the Food ChainImmunohistochemical localization of caffeine-induced c-Fos protein expression in the rat brain.Multiple pathways for elevating extracellular adenosine in the rat hippocampal CA1 region characterized by adenosine sensor cells.Caffeine impairs gastrointestinal function in newborn rats.Disposition kinetics of caffeine and paraxanthine in Nile tilapia (Oreochromis niloticus): characterization of the main metabolites.[Mechanisms of caffeine-induced diuresis].
P2860
Q28188530-E2716D7D-ECB4-4BB4-B5B8-09F81C12226CQ28243209-389832E9-D860-4F17-ADD5-DF054E1F57DEQ29540785-AD086249-7B01-4797-B69E-BC2D033AC0D6Q33729422-DC88F1DE-AF13-47F2-AA7D-79A9A70FE962Q33794389-096FC213-FE99-4B64-9349-648F435EDE30Q33816026-627B7A20-BF4E-4930-B9E0-C16B83A8AF45Q34220383-C60CAC79-BB17-4BD8-9A67-826DEE7635E8Q34673370-905C1CC8-97B2-47EA-A422-3B7BCD3E8E41Q34743637-9D36BDD4-FD4F-4E2D-BBA6-FB5BAC67530DQ34755385-0079333D-163F-4C79-B162-9FA6FA09FC15Q35015993-78E3D360-10D4-46C1-8265-C9FEE15DA2B9Q35776784-45A052F1-2CA7-41B2-8575-BA720F717F54Q35977237-C978160C-E7F0-43CE-B869-3FB87588154BQ36328984-5C3EB87B-E9CA-4881-A275-FCE36FBA8DC0Q37052182-E6384907-226B-4098-8719-E59876A724E6Q37158637-181A61ED-8E4A-4A8E-892A-220AC6433295Q37451782-7C518268-2999-4BD4-B7D3-480FEE75E0E9Q37675003-C984D8E1-F997-4F8D-BA56-700662EB785CQ38196459-7411B543-AE08-4E21-A4A3-7D357C838397Q38621333-AFDF9163-0F21-4C82-B201-5F9E94248050Q39415415-C705C30B-EF26-4A93-9F8A-CFD06ED49D84Q42245955-5151D351-46E9-407E-ADDB-DDCC6C8D5928Q42416756-C5F25D8E-9D34-4EE9-9196-B3463B81F578Q42777491-8CD8EF3D-51B6-46DA-B347-D6A4E0F932AEQ43175571-A6FE1ED1-2A6F-489E-A76F-3B95C06A00B1Q43502870-E624374C-354C-402A-A1EC-B7251E2C6DE1Q46316146-8F3CC894-9B75-4C27-B09C-234819067624Q47145688-FF77A6AC-4405-45A5-9D55-B92C20939EDBQ48358807-1E28B57F-8B40-4A56-91AC-7A6B8DAFD36EQ48413487-7E90E413-009E-469B-93E5-A1C477BF2F4CQ51305872-4D991443-C9CD-4D85-82C4-57F76156D03DQ51903122-2BE37F8D-EE80-429E-A268-C9F79A43B99AQ53080189-82CDA75A-78F0-449D-80C8-D1F81168951B
P2860
Pharmacological rationale for the clinical use of caffeine.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Pharmacological rationale for the clinical use of caffeine.
@ast
Pharmacological rationale for the clinical use of caffeine.
@en
Pharmacological rationale for the clinical use of caffeine.
@nl
type
label
Pharmacological rationale for the clinical use of caffeine.
@ast
Pharmacological rationale for the clinical use of caffeine.
@en
Pharmacological rationale for the clinical use of caffeine.
@nl
prefLabel
Pharmacological rationale for the clinical use of caffeine.
@ast
Pharmacological rationale for the clinical use of caffeine.
@en
Pharmacological rationale for the clinical use of caffeine.
@nl
P1433
P1476
Pharmacological rationale for the clinical use of caffeine.
@en
P2093
P356
10.2165/00003495-199549010-00004
P577
1995-01-01T00:00:00Z
P5875
P6179
1042505921